1. Int J Dermatol. 2020 Aug;59(8):e303-e305. doi: 10.1111/ijd.14829. Epub 2020
Mar  11.

The effect of metformin on the risk of recurrent nonmelanoma skin cancers.

Ravishankar A(1), Zhang T(2), Lindgren BR(3), Farah RS(4), Dong Z(2), Goldfarb 
NI(5)(6).

Author information:
(1)University of Minnesota Medical School, Minneapolis, MN, USA.
(2)The Hormel Institute, University of Minnesota, Austin, MN, USA.
(3)Masonic Cancer Center, University of Minnesota Biostatistics Core, 
Minneapolis, MN, USA.
(4)Department of Dermatology, University of Minnesota, Minneapolis, MN, USA.
(5)Departments of Medicine and Dermatology, University of Minnesota, 
Minneapolis, MN, USA.
(6)Departments of Medicine and Dermatology, Minneapolis VA Medical Center, 
Minneapolis, MN, USA.

DOI: 10.1111/ijd.14829
PMCID: PMC7673232
PMID: 32162316 [Indexed for MEDLINE]

Conflict of interest statement: Conflict of interest: None.
